Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma

被引:36
作者
Arcuri, F
Cintorino, M
Florio, P
Floccari, F
Pergola, L
Romagnoli, R
Petraglia, F
Tosi, P
del Vecchio, MT
机构
[1] Univ Siena, Inst Pathol Anat & Histol, I-53100 Siena, Italy
[2] Univ Siena, Dept Obstet & Gynecol, I-53100 Siena, Italy
[3] Univ Siena, Inst Gen Physiol, I-53100 Siena, Italy
关键词
UCN; prostatic tissue; reverse-transcription polymerase chain reaction; immunohistochemistry;
D O I
10.1002/pros.10094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Urocortin (UCN) is a recently described neuropeptide member of the CRF family, responsible for the secretion of the proopiomelanocortin-derived peptides from the pituitary gland. Although previous results have demonstrated the synthesis of several neuroendocrine factors in the prostate, no studies have been carried out on the expression of UCN in the human gland. METHODS. UCN expression was evaluated in benign prostatic hyperplasia and prostatic tumor tissues by RT-PCR and immunohistochemistry. RESULTS. UCN mRNA and peptide were demonstrated in all specimens tested. In nonneoplastic tissues, UCN was localized in the secretory luminal epithelial and basal layer cells, in the smooth muscle component of the stroma, and in lymphoid infiltrates. An intense immunostaining was evident in prostate adenocarcinoma cells. CONCLUSIONS. The results of the present study demonstrate for the first time UCN expression in the human prostate and in prostate cancer, and suggest a potential involvement of UCN in prostate physiopathology. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 33 条
  • [1] Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO
  • [2] 2-S
  • [3] Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin
    Agnello, D
    Bertini, R
    Sacco, S
    Meazza, C
    Villa, P
    Ghezzi, P
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 275 (05): : E757 - E762
  • [4] Arcuri F, 1999, PROSTATE, V39, P159, DOI 10.1002/(SICI)1097-0045(19990515)39:3<159::AID-PROS3>3.0.CO
  • [5] 2-M
  • [6] IMMUNOHISTOLOGIC LOCALIZATION OF CORTICOTROPIN-RELEASING HORMONE IN HUMAN-TUMORS
    ASA, SL
    KOVACS, K
    VALE, W
    PETRUSZ, P
    VECSEI, P
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (03) : 327 - 333
  • [7] Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone
    Asaba, K
    Makino, S
    Hashimoto, K
    [J]. BRAIN RESEARCH, 1998, 806 (01) : 95 - 103
  • [8] Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells
    Bahk, JY
    Hyun, JS
    Lee, H
    Kim, MO
    Cho, GJ
    Lee, BH
    Choi, WS
    [J]. UROLOGICAL RESEARCH, 1998, 26 (04): : 259 - 264
  • [9] The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
    Bairoch, A
    Apweiler, R
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 45 - 48
  • [10] Human lymphocytes produce urocortin, but not corticotropin-releasing hormone
    Bamberger, CM
    Wald, M
    Bamberger, AM
    Ergün, S
    Beil, FU
    Schulte, HM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) : 708 - 711